Virios Therapeutics, Inc.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed d…
Biotechnology
US, Alpharetta [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Virios Therapeutics, Inc. (VIRI) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - - Average | - - | - - | - - | 610,106.49 | 22,676.61 | 2,559.63 | 1,107.95 | 816.49 | 0.00 | 24.5384 | 57.21 | -0.4583 | -17.0519 | -0.07 | -0.64 | 6.2847 | - - | |
| Maximum | - - | - - | - - | 66,761,212.00 | 1,187,075.00 | 264,468.00 | 99,050.00 | 262,089.00 | 0.02 | 1,336.3467 | 3,715.80 | 3.0051 | 85.3485 | 0.40 | 2.21 | 73.1011 | - - | |
| Minimum | - - | - - | - - | 0.00 | -149.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -233.7460 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -84.15 | 0.0000 | - - | |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.